Skip to content

Latest News & Updates

Find out what has been happening at Excellerate Bioscience, including when and where we will be attending conferences, meetings and networking events.

Building Photo 2048x1510
Featured 1st January, 2023

Excellerate Bioscience Announces Site Relocation

Read More
Excellerate and Biocell Energetics partner to advance mitochondrial toxicity screening

Excellerate and Biocell Energetics partner to advance mitochondrial toxicity screening

Read More
Spotlight: GPCR Assay Technologies

Spotlight: GPCR Assay Technologies

Read More
Blog: Process & Challenges in Modern Preclinical Drug Discovery

Blog: Process & Challenges in Modern Preclinical Drug Discovery

Read More
Publication in The Journal of Pharmacology and Experimental Therapeutics: Novel Mitochondrial Modulation

Publication in The Journal of Pharmacology and Experimental Therapeutics: Novel Mitochondrial Modulation

Read More
Excellerate Bioscience Achieves Zero Carbon Electricity for Business

Excellerate Bioscience Achieves Zero Carbon Electricity for Business

Read More
Novel treatment mechanism for diabesity published in Molecular Metabolism

Novel treatment mechanism for diabesity published in Molecular Metabolism

Read More
Publication: Chemokine receptor pharmacology through design of fluorescent allosteric modulators

Publication: Chemokine receptor pharmacology through design of fluorescent allosteric modulators

Read More
Excellerate Bioscience Announces Site Relocation

Excellerate Bioscience Announces Site Relocation

Read More
Excellerate Bioscience announces multiple staff appointments to expand immunology and biochemical pharmacology expertise

Excellerate Bioscience announces multiple staff appointments to expand immunology and biochemical pharmacology expertise

Read More
Cisbio and Excellerate Bioscience partner on ligand kinetic binding services

Cisbio and Excellerate Bioscience partner on ligand kinetic binding services

Read More
Excellerate Bioscience in successful EU consortium bid to develop new obesity therapeutics

Excellerate Bioscience in successful EU consortium bid to develop new obesity therapeutics

Read More
AdAlta and Excellerate Bioscience collaborate to advance the development of i-body pipeline

AdAlta and Excellerate Bioscience collaborate to advance the development of i-body pipeline

Read More
Leigh Stoddart joins the team as Associate Principal Scientist

Leigh Stoddart joins the team as Associate Principal Scientist

Read More
Excellerate Bioscience client AdoRx announces strategic partnership with Johnson & Johnson

Excellerate Bioscience client AdoRx announces strategic partnership with Johnson & Johnson

Read More
Excellerate contribute to success of Omass Therapeutics

Excellerate contribute to success of Omass Therapeutics

Read More